Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets

被引:12
|
作者
Hsu, Michael [1 ,7 ]
Jung, Olivia S. [3 ]
Kwan, Li Ting [4 ]
Jegede, Oluwole [5 ]
Martin, Bianca [6 ]
Malhotra, Aniket [2 ]
Suzuki, Joji [6 ]
机构
[1] Greater Los Angeles VA Med Ctr, Dept Psychiat, Los Angeles, CA USA
[2] Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA USA
[3] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA
[4] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA
[5] Yale Sch Med, Dept Psychiat, New Haven, CT USA
[6] Brigham & Womens Hosp, Div Addict Psychiat, Boston, MA USA
[7] 11301 Wilshire Blvd,Bldg 210A, Los Angeles, CA 90073 USA
来源
JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT | 2024年 / 157卷
关键词
Medications for opioid use disorder; Buprenorphine; Health equity; Treatment access; Opioid use disorder; CHOOSING BUPRENORPHINE; PATIENT PERSPECTIVES; METHADONE TREATMENT; ADDICTION; STIGMA; RACE;
D O I
10.1016/j.josat.2023.209216
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Achieving equitable access to medications for opioid use disorder (MOUD) such as buprenorphine is a pressing issue. Evidence suggests disparities in MOUD access based on race and socioeconomic status, further exacerbated by the COVID-19 pandemic. However, the drivers behind this access gap remain poorly understood. This study explores barriers to treatment access among individuals with opioid use disorder (OUD) experiencing homelessness.Methods: We interviewed 28 individuals in and around the Boston Public Health Commission (BPHC) Engagement Center, an area known for its high density of active substance use and homelessness. We asked about people's experiences, perceptions, and attitudes toward OUD treatment. We conducted a thematic analysis of our interview data.Results: Fifty-four percent of participants sampled were not prescribed MOUD. None of the participants reported having an active prescription of sublingual buprenorphine or buprenorphine/naloxone. White participants were more likely to have been prescribed buprenorphine in the past compared to participants of other races even in this socioeconomically homogeneous sample. Themes that emerged in our data included challenges to accessing MOUD due to reduced services during the COVID-19 pandemic, lost or stolen medications, fewer inpatient withdrawal management beds for women, transportation challenges, fear of adverse effects of MOUD, the perception that taking MOUD replaces one addiction for another, and community disapproval of MOUD. Participants also reported stigma and discrimination based on race, gender, and socioeconomic status. Conclusion: Systems and individual-level factors contribute to the MOUD treatment gap across race and socioeconomic status. The COVID-19 pandemic posed additional access challenges. This study provides important, actionable insights about the barriers faced by a particularly vulnerable population of individuals with OUD experiencing homelessness.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Exploring opioid use disorder, its impact, and treatment among individuals experiencing homelessness as part of a family
    Chatterjee, Avik
    Yu, Eun Jin
    Tishberg, Lindsay
    DRUG AND ALCOHOL DEPENDENCE, 2018, 188 : 161 - 168
  • [2] Comorbid Health Conditions and Treatment Utilization among Individuals with Opioid Use Disorder Experiencing Homelessness
    Ali, Mir M.
    Sutherland, Harper
    Rosenoff, Emily
    SUBSTANCE USE & MISUSE, 2021, 56 (04) : 571 - 574
  • [3] National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness
    Han, Benjamin H.
    Doran, Kelly M.
    Krawczyk, Noa
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 132
  • [4] Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder
    Kudrich, Christopher
    Chen, Rebecca
    Meng, Yuan
    Bachi, Keren
    Hurd, Yasmin L.
    HARM REDUCTION JOURNAL, 2024, 21 (01)
  • [5] Opioid use disorder treatment for people experiencing homelessness: A scoping review
    McLaughlin, Matthew F.
    Li, Rick
    Carrero, Nicolas Dominguez
    Bain, Paul A.
    Chatterjee, Avik
    DRUG AND ALCOHOL DEPENDENCE, 2021, 224
  • [6] Attitudes and Subjective Norms Regarding Medication for Opioid Use Disorder Among Individuals in Treatment for Opioid Use Disorder in the Greater St. Louis Area
    Filiatreau, Lindsey M.
    Szlyk, Hannah S.
    Kasson, Erin
    Dickson, Megan F.
    Banks, Devin
    Winograd, Rachel
    Marotta, Phillip
    Cavazos-Rehg, Patricia
    JOURNAL OF DRUG ISSUES, 2025, 55 (03) : 401 - 419
  • [7] A National Study of Homelessness, Social Determinants of Health, and Treatment Engagement Among Outpatient Medication for Opioid Use Disorder-Seeking Individuals in the United States
    Gaeta Gazzola, Marina
    Carmichael, Iain D.
    Christian, Nicholaus J.
    Zheng, Xiaoying
    Madden, Lynn M.
    Barry, Declan T.
    SUBSTANCE ABUSE, 2023, 44 (1-2) : 62 - 72
  • [8] Treatment access for opioid use disorder among women with medicaid in Florida
    Elmore, Amanda L.
    Patrick, Stephen W.
    McNeer, Elizabeth
    Fryer, Kimberly
    Reid, Chinyere N.
    Sappenfield, William M.
    Mehra, Saloni
    Salemi, Jason L.
    Marshall, Jennifer
    DRUG AND ALCOHOL DEPENDENCE, 2023, 246
  • [9] ?Sick and tired of being sick and tired?: Exploring initiation of medications for opioid use disorder among people experiencing homelessness
    Swartz, Natalie
    Adnan, Tatheer
    Perea, Flavia
    Baggett, Travis P.
    Chatterjee, Avik
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 138
  • [10] Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder
    Gryczynski, Jan
    Nichols, Helen
    Schwartz, Robert P.
    Mitchell, Shannon Gwin
    Hill, Paulette
    Wireman, Kim
    DRUG AND ALCOHOL DEPENDENCE, 2019, 204